Insilico's AI-designed fibrosis drug cuts predicted biological age by ~3 years
Polymarket · x · 2026-09-09
Insilico Medicine says its AI-designed fibrosis drug produced an average 3-year drop in predicted biological age among participants, prompting the company to claim "we might have a chance to stop biological aging." Details on sample size and mechanism are not yet disclosed.
Related event: Insilico's AI-designed drug appears to slow biological aging(2 posts)→
More from Research
- UK AISI: under $80 of fine-tuning fully restores filtered bio capabilities in open-weight models — connoraxiotes · 2026-10-27
- RFD4-Proteina runs on an RTX 3060: protein design from $0.001 per design — AllThingsApx · 2026-10-27
- University of Freiburg's Generative Intelligence Lab recruiting funded PhDs via ELLIS, apply by Oct 31 — yuyinzhou_cs · 2026-10-27
- Nature Physics: reprogrammable refractive index enables arbitrary multimode wave control for ML — MarioKrenn6240 · 2026-10-27
- Wakaru open-sources ontologize: labeling datasets from model activations — amplifiedamp · 2026-10-27
- EMNLP Oral paper traces multilingual representations in LLMs with cross-layer transcoders — ZhijingJin · 2026-10-27